Holen Sie sich die Stockscreener-App
25.91
1.41%
0.36
Handel nachbörslich:
25.91
Assembly Biosciences Inc Aktie (ASMB) Neueste Nachrichten
ASMB|Assembly Biosciences Inc|Price:26.155|Chg%:+0.605 - TradingKey
Assembly Biosciences Inc (ASMB) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Assembly Biosciences Inc (ASMB) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Assembly Biosciences Inc (ASMB) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
TradingKey - TradingKey
Assembly Biosciences Market Sentiment - Benzinga España
Assembly Biosciences Inc (ASMB) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Assembly Biosciences Inc (ASMB) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Avoiding Lag: Real-Time Signals in (ASMB) Movement - Stock Traders Daily
Assembly Biosciences Closes Securities Offering - Moomoo
Assembly Biosciences strengthens antiviral plat... - Pluang
Assembly Biosciences: A Gilead-Backed Antiviral Option With More Embedded Leverage Than The Market Appreciates - Seeking Alpha
Assembli to Produce Big Ten Conference Activation at Fanatics Fest in New York - GlobeNewswire Inc.
Enterprise value to EBIT forward of Assembly Biosciences, Inc. – NASDAQ:ASMB - TradingView
Enterprise value to EBIT forward of Assembly Biosciences, Inc. – HAM:V7B - TradingView
Enterprise value to EBIT forward of Assembly Biosciences, Inc. – FWB:V7B - TradingView
Price to earnings forward of Assembly Biosciences, Inc. – FWB:V7B - TradingView
Enterprise value to revenue forward of Assembly Biosciences, Inc. – NASDAQ:ASMB - TradingView
Assembly Biosciences (ASMB) Holds Steady Near Resistance ZoneOverbought Signal Alerts - dars.gov.et
Enterprise value to EBITDA forward of Assembly Biosciences, Inc. – NASDAQ:ASMB - TradingView
Assembly Biosciences Inc: Plans to Initiate a - Moomoo
ASMBAssembly Biosciences Inc Options - Finviz
Discipline and Rules-Based Execution in ASMB Response - Stock Traders Daily
Assembly Biosciences, Inc.(NasdaqGS: ASMB) added to Russell 2000 Index - marketscreener.com
Assembly Biosciences, Inc.(NasdaqGS: ASMB) added to Russell 2000 Value Benchmark - marketscreener.com
Assembly Biosciences, Inc.(NasdaqGS: ASMB) added to Russell 3000E Index - marketscreener.com
Assembly Biosciences, Inc.(NasdaqGS:ASMB) dropped from Russell 3000E Growth Benchmark - marketscreener.com
Assembly Biosciences, Inc.(NasdaqGS: ASMB) added to Russell 3000 Value Benchmark - marketscreener.com
Assembly Biosciences, Inc.(NasdaqGS: ASMB) added to Russell 3000 Index - marketscreener.com
Health Care had the best week vs. the S&P 500 on record (XLV:NYSEARCA) - Seeking Alpha
Assembly Biosciences, Inc. Actuals & Estimates (NASDAQ:ASMB) - TradingView
Assembly Biosciences, Inc. Actuals & Estimates (TRADEGATE:V7B) - TradingView
ASMB Forecast — Price Target — Prediction for 2027 - TradingView
Assembly Biosciences Inc (ASMB) Institutional Confidence - TradingKey
Behavioral Patterns of ASMB and Institutional Flows - Stock Traders Daily
Assembly Biosciences (ASMB) PFO sells 29 shares to cover RSU taxes - Stock Titan
Assembly Biosciences Inc (ASMB) Valuation: PE, PB & Fair Value Analysis - TradingKey
Assembly Biosciences Inc (ASMB) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Assembly Biosciences Inc (ASMB) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
ASMB Maintained by Mizuho -- Price Target Raised to $45 - GuruFocus
Mizuho Raises Price Target on Assembly Biosciences to $45 From $40, Keeps Outperform Rating - Moomoo
ZVRA Stock Price and Chart — NASDAQ:ZVRA - TradingView
Assembly Biosciences eyes Gilead HSV plan as ABI-6250 liver pipeline expands - MSN
ASMB SEC FilingsAssembly Bioscie 10-K, 10-Q, 8-K Forms - Stock Titan
Assembly Biosciences Teases Gilead HSV-2 Decision, Liver Disease Data Ahead - MarketBeat
(ASMB) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Assembly Biosciences Expands Equity Plans, Reelects Board - TipRanks
Assembly Biosciences (ASMB) CMO awarded 14,000-share RSU-based stock grant - Stock Titan
Assembly Biosciences (ASMB) CMO awarded 14,000 restricted stock units - Stock Titan
Assembly Biosciences (NASDAQ: ASMB) awards 8,000 stock options to director McHutchison - Stock Titan
Assembly Biosciences (ASMB) director receives grant of 8,000 stock options - Stock Titan
Director at Assembly Biosciences (ASMB) receives grant of 8,000 stock options - Stock Titan
Assembly Biosciences (NASDAQ: ASMB) director receives 8,000 stock options grant - Stock Titan
Assembly Biosciences (NASDAQ: ASMB) director receives grant of 8,000 stock options - Stock Titan
Director at Assembly Biosciences (NASDAQ: ASMB) receives 8,000 options - Stock Titan
Assembly Biosciences (NASDAQ: ASMB) PFO awarded 3,500 RSUs - Stock Titan
Assembly Biosciences (ASMB) CSO granted 14,000 RSUs tied to plan amendment - Stock Titan
Assembly Biosciences (ASMB) CEO receives 50,750 RSUs in equity grant - Stock Titan
Assembly Biosciences (ASMB) shareholders back directors, equity plan and ESPP share hikes - Stock Titan
Assembly Biosciences Eyes Gilead HSV Plan as ABI-6250 Liver Pipeline Expands - Yahoo Finance
1.97%
0.83%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):